Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

32,811 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Toripalimab in Combination With Induction Chemotherapy and Subsequent Chemoradiation as First-Line Treatment in Patients With Advanced/Metastatic Esophageal Carcinoma: Protocol for a Single-Arm, Prospective, Open-Label, Phase II Clinical Trial (TR-EAT).
Wu L, Wang Y, Li B, Wan G, Liang L, Li T, Lang J, Wang Q. Wu L, et al. Front Oncol. 2022 Apr 8;12:878851. doi: 10.3389/fonc.2022.878851. eCollection 2022. Front Oncol. 2022. PMID: 35463350 Free PMC article.
Effectiveness and safety of first-line pembrolizumab plus chemotherapy in patients with advanced/recurrent or metastatic esophageal squamous cell carcinoma in China: a real-world multicenter study.
Lin Y, Shen W, Ye J, Luo H, Zhang X, Xu Y, Lin Q, Liu W, Zhang Y, Xu Y, Jiang W, Zhao L, Liu A, Wu L, Ge H, Xie C, Zhao K, Chen J, Wang L, Liu Q. Lin Y, et al. Among authors: wu l. Ther Adv Med Oncol. 2024 Nov 19;16:17588359241297092. doi: 10.1177/17588359241297092. eCollection 2024. Ther Adv Med Oncol. 2024. PMID: 39563718 Free PMC article.
32,811 results
You have reached the last available page of results. Please see the User Guide for more information.